Incyte Corporation (INCY) fundamentals score
Incyte is a global biopharmaceutical company engaged in the discovery, development and commercialization of proprietary therapeutics. Its global headquarters is located in Wilmington, Delaware, where it conducts discovery, clinical development and commercial operations.
Services-Commercial Physical & Biological Research · Industrials · Listed on NASDAQ
Overall: 8.3 out of 10, Strong long-term fundamentals
- Growth: 6.9/10
- Profitability: 9.4/10
- Financial health: 9.5/10
- Earnings quality: 7.5/10
- Valuation: 8.3/10
Scores are calculated from Incyte Corporation’s SEC filings, using the 12 months through 2026-03. Compare it with past big winners, check its flags, and see today’s price against its fundamentals in the full scorecard.
Other Industrials stocks
- Sezzle Inc. (SEZL): 9.1/10
- Paymentus Holdings, Inc. (PAY): 8.7/10
- Argan Inc. (AGX): 8.6/10
- Ferguson Enterprises Inc. (FERG): 8.6/10
- International Seaways, Inc. (INSW): 8.6/10
- Dorian Lpg Ltd. (LPG): 8.6/10
- Quinstreet, Inc. (QNST): 8.6/10
- Remitly Global, Inc. (RELY): 8.6/10